ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,136Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 324

$604K Total Retail Price of All Prescriptions

Rank: 67 out of 324

545 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 545 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 545 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 8,678 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 572 497 1 2
SIMVASTATIN 470 444 2 1
HYDROCHLOROTHIAZIDE 424 389 3 11
OMEPRAZOLE 349 273 4 6
HYDROCODONE-ACETAMINOPHEN 321 224 S3 5 5
FUROSEMIDE 276 242 6 7
METFORMIN HCL 255 218 7 9
GABAPENTIN 235 217 8 13
AMLODIPINE BESYLATE 228 209 9 4
LISINOPRIL 211 177 10 3
ATORVASTATIN CALCIUM 184 166 11 12
ATENOLOL 153 153 12 18
METOPROLOL TARTRATE 138 127 13 14
RAMIPRIL 126 119 14 104
TAMSULOSIN HCL 111 107 15 26
TRAMADOL HCL 106 88 16 19
ALENDRONATE SODIUM 100 87 17 24
PROPRANOLOL HCL 95 80 18 95
ESCITALOPRAM OXALATE 89 69 19 54
SYNTHROID 89 79 19 30
POTASSIUM CHLORIDE 82 75 21 8
ENALAPRIL MALEATE 80 77 22 57
WARFARIN SODIUM 79 72 23 10
CRESTOR 77 57 24 28
CITALOPRAM HBR 75 51 25 16
IBUPROFEN 73 39 26 130
DONEPEZIL HCL 72 68 27 25
CARVEDILOL 71 67 28 22
TRAZODONE HCL 71 31 28 42
SPIRONOLACTONE 70 62 30 47
METOPROLOL SUCCINATE 69 68 31 17
ADVAIR DISKUS 65 58 32 61
ZETIA 63 59 33 68
ZOLPIDEM TARTRATE 63 56 33 20
DILTIAZEM ER 62 62 35 128
CYCLOBENZAPRINE HCL 61 27 R 36 51
FLUTICASONE PROPIONATE 60 39 37 32
PROBENECID 60 60 37 340
QUINAPRIL HCL 57 57 39 186
DICLOFENAC SODIUM 57 29 39 114
NEXIUM 57 52 39 33
CLOPIDOGREL 56 54 42 38
PRAVASTATIN SODIUM 55 37 43 21
PANTOPRAZOLE SODIUM 54 36 44 34
SPIRIVA 54 54 44 70
GLYBURIDE 53 49 R 46 59
CARBIDOPA-LEVODOPA 52 49 47 80
FLUOXETINE HCL 52 38 47 67
LOSARTAN POTASSIUM 51 47 49 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.